US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ADARx Pharmaceuticals

19.94

-0.6950-3.37%

Post-market: 20.300.3600+1.81%19:30 EDT

Volume:788.84K

Turnover:16.16M

Market Cap:2.04B

PE:-2.58

High:21.61

Open:20.65

Low:19.23

Close:20.64

52wk High:23.21

52wk Low:18.50

Shares:102.20M

Float Shares:102.20M

Volume Ratio:0.35

T/O Rate:0.77%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.7403

EPS(LYR):-6.4321

ROE:-38.89%

ROA:-14.90%

PB:-8.12

PE(LYR):-3.10

Loading ...

Overview Company News Filings

Company Profile

Company Name:

ADARx Pharmaceuticals

Exchange:

NASDAQ

Establishment Date:

2019

Employees:

- -

Office Location:

5871 Oberlin Drive,Suite 200,San Diego,California,United States

Website:

http://www.adarx.com

Zip Code:

92121

Phone:

Fax:

- -

Introduction:

ADARx Pharmaceuticals, Inc. is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. The company is advancing a pipeline of highly potent, selective and durable siRNA therapeutic candidates, including three clinical-stage programs targeting complement-mediated diseases, hereditary angioedema and thrombotic diseases, as well as two advanced preclinical programs targeting obesity and neurodegenerative diseases.

Directors

Name

Position

Erez Chimovits

Director and Interim Chairman of the Board

Zhen Li

Chief Executive Officer and Director and President

Carl L. Gordon

Director

Chen Yu

Director

Judith J. Li

Director

Mary Tagliaferri

Director

Ricky Sun

Director

Simeon George

Director

Ting Feng

Director

Ying Huang

Director

Shareholders

Name

Position

Zhen Li

Chief Executive Officer and Director and President

Ryan Fisk

Chief Business Officer and Chief Financial Officer

A. Robert MacLeod

Chief Scientific Officer

Robert Ackles

Chief People Officer

Rui Zhu

Chief Technology Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/ADRX/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADRX\",,,,,undefined,":{"symbol":"ADRX","market":"US","secType":"STK","nameCN":"ADARx Pharmaceuticals","latestPrice":19.94,"timestamp":1790798400000,"preClose":20.635,"halted":0,"volume":788842,"hourTrading":{"tag":"盘后","latestPrice":20.3,"preClose":19.94,"latestTime":"19:30 EDT","volume":8271,"amount":165443.004,"timestamp":1790811003420,"change":0.36,"changeRate":0.018054,"amplitude":0.019559},"delay":0,"changeRate":-0.03368063968984736,"floatShares":102200905,"shares":102200905,"eps":-7.740306,"marketStatus":"Not Yet Opened","change":-0.695,"latestTime":"09-30 16:00:00 EDT","open":20.65,"high":21.61,"low":19.23,"amount":16157101.2861,"amplitude":0.115338,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.740306,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790841600000},"marketStatusCode":0,"adr":0,"listingDate":1790308800000,"exchange":"NASDAQ","adjPreClose":20.635,"preHourTrading":{"tag":"盘前","latestPrice":21,"preClose":20.635,"latestTime":"09:14 EDT","volume":178,"amount":3713.5997599999996,"timestamp":1790774086918,"change":0.365,"changeRate":0.017688,"amplitude":0.033923},"postHourTrading":{"tag":"盘后","latestPrice":20.3,"preClose":19.94,"latestTime":"19:30 EDT","volume":8271,"amount":165443.004,"timestamp":1790811003420,"change":0.36,"changeRate":0.018054,"amplitude":0.019559},"volumeRatio":0.352245},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADRX\",,,,,undefined,":{"symbol":"ADRX","floatShares":102200905,"roa":"-14.90%","roe":"-38.89%","lyrEps":-6.432121,"volumeRatio":0.352245,"shares":102200905,"dividePrice":0,"high":21.61,"amplitude":0.115338,"preClose":20.635,"low":19.23,"week52Low":18.5,"pbRate":"-8.12","psRate":"332.61","week52High":23.21,"institutionHeld":0,"latestPrice":19.94,"eps":-7.740306,"divideRate":0,"volume":788842,"delay":0,"ttmEps":-7.740306,"open":20.65,"prevYearClose":17,"prevWeekClose":19.35,"prevMonthClose":17,"prevQuarterClose":17,"fiveDayClose":17,"twentyDayClose":17,"sixtyDayClose":17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADRX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADRX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADRX","date":"2026-09-29","current":-2.576126,"percent":0,"low":-24.41833,"twenty":-24.228516,"median":-23.943795,"eighty":-23.659073,"high":-23.469259,"avg":-23.943795,"sd":0.474535,"marketCap":2145638619},"quantilePoints":[{"date":"2026-09-29","current":-24.41833,"twenty":-24.228516,"median":-23.943795,"eighty":-23.659073,"marketCap":2145638619}],"updateTime":1790827184655},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":653770897,"yearFounded":2019,"address":"5871 Oberlin Drive,Suite 200,San Diego,California,United States","zipCode":"92121","officePhone":"(877) 232-7974","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.adarx.com","stockEarnings":[{"period":"1week","weight":0.2138},{"period":"ytd","weight":0.2138}],"compareEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":-0.0067},{"period":"3month","weight":0.0247},{"period":"6month","weight":0.1652},{"period":"1year","weight":0.1515},{"period":"ytd","weight":0.1207}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ADARx Pharmaceuticals, Inc. is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. The company is advancing a pipeline of highly potent, selective and durable siRNA therapeutic candidates, including three clinical-stage programs targeting complement-mediated diseases, hereditary angioedema and thrombotic diseases, as well as two advanced preclinical programs targeting obesity and neurodegenerative diseases.","exchange":"NASDAQ","name":"ADARx Pharmaceuticals","nameEN":"ADARx Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ADRX\",market:\"US\",,,undefined,":{"directors":[{"name":"Erez Chimovits","position":"Director and Interim Chairman of the Board"},{"name":"Zhen Li","position":"Chief Executive Officer and Director and President"},{"name":"Carl L. Gordon","position":"Director"},{"name":"Chen Yu","position":"Director"},{"name":"Judith J. Li","position":"Director"},{"name":"Mary Tagliaferri","position":"Director"},{"name":"Ricky Sun","position":"Director"},{"name":"Simeon George","position":"Director"},{"name":"Ting Feng","position":"Director"},{"name":"Ying Huang","position":"Director"}],"executives":[{"name":"Zhen Li","position":"Chief Executive Officer and Director and President"},{"name":"Ryan Fisk","position":"Chief Business Officer and Chief Financial Officer"},{"name":"A. Robert MacLeod","position":"Chief Scientific Officer"},{"name":"Robert Ackles","position":"Chief People Officer"},{"name":"Rui Zhu","position":"Chief Technology Officer"}]}}}